Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gormley

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Elife|October 9, 2025
Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization studyFernanda Morales Berstein, Jasmine Khouja, Mark Gormley, et al.
Plos One|March 10, 2022
A clinical observational analysis of aerosol emissions from dental proceduresTom Dudding, Sadiyah Sheikh, Florence Gregson, et al.
Pediatrics|January 28, 2016
AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled TrialMauricio R Delgado, Ann Tilton, Barry Russman, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
Head & Neck|June 8, 2024
Development and external validation of a head and neck cancer risk prediction modelCraig D L Smith, Alex D McMahon, Donald M Lyall, et al.
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
Nature Communications|October 2, 2025
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsitesElmira Ebrahimi, Apiwat Sangphukieo, Hanla A Park, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Elife|October 9, 2025
Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization studyFernanda Morales Berstein, Jasmine Khouja, Mark Gormley, et al.
Plos One|March 10, 2022
A clinical observational analysis of aerosol emissions from dental proceduresTom Dudding, Sadiyah Sheikh, Florence Gregson, et al.
Pediatrics|January 28, 2016
AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled TrialMauricio R Delgado, Ann Tilton, Barry Russman, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
Head & Neck|June 8, 2024
Development and external validation of a head and neck cancer risk prediction modelCraig D L Smith, Alex D McMahon, Donald M Lyall, et al.
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
Nature Communications|October 2, 2025
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsitesElmira Ebrahimi, Apiwat Sangphukieo, Hanla A Park, et al.
Pageof 5